News

According to Vantage Market Research, the Global Flow Cytometry Market is estimated to be valued at USD 14 Billion by 2035 at ...
Crown BioScience experts explore organoid models and high-content imaging to evaluate T-cell-targeted therapies and ...
This has enabled the lab to test multiple samples against multiple ... Furthermore, the lab has implemented flow cytometry data analysis software that can process multicolour files of up to ...
Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, introduces the Next-Generation ...
Driven EcosystemsDublin, April 08, 2025 (GLOBE NEWSWIRE) -- The "Minimal Residual Disease Testing Market by Product Type (Instruments, Reagents & Kits, Software & Services), Test Techniques (Flow ...
Powered Research, a leading preclinical CRO specializing in non-GLP models, has launched its oncology models and research services tailored to meet the unique needs of life science R&D companies. This ...
In an era marked by remarkable advancements in medical diagnostics, the global minimal residual disease (MRD) testing market is poised for unprecedented growth. Projections suggest that by 2031, the ...
The following is a summary of “Cytokeratin 17 activates AKT signaling to induce epithelial-mesenchymal transition and promote bladder cancer progression,” published in the April 2025 issue of BMC ...
The following is a summary of “Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumab,” published in the April 2025 issue of Journal of ...
Kanazawa University and colleagues have developed a promising new approach to cancer treatment. By using tiny, naturally ...